Novartis To Spin Off Generics Business Sandoz

Novartis Announced Its Intention To Separate Sandoz, Its Generics And Biosimilars Division Into A New Publicly Traded Standalone Company, By Way Of A 100% Spin-Off.The Spin-Off Aims To Maximize Shareholder Value By Creating The #1 European Generics Company And A Global Leader In Biosimilars, Allowing Novartis Shareholders To Participate Fully In The Potential Future Upside For Both Sandoz And Novartis Innovative Medicines.For Both The Innovative Medicines And Sandoz Businesses, The Spin-Off Would Enable Enhanced Focus And The Ability To Pursue Independent Growth Strategies. Sandoz Is Expected To Deliver Its Next Wave Of Growth Based On The Existing Biosimilars Pipeline Of 15+ Molecules, A Strong And Experienced Management Team And Organization. Novartis Aims To Become A Focused Innovative Medicines Company With A Stronger Financial Profile, And Improved Return On Capital.The Standalone Sandoz Would Be Headquartered In Switzerland And Listed On The Six Swiss Exchange, With An American Depositary Receipt (Adr) Program In The Us.Joerg Reinhardt, Chair Of The Board Of Directors Of Novartis, Said:

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!